𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

✍ Scribed by Suzanne L. Topalian

Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
693 KB
Volume
6
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CIITA-driven MHC-II positive tumor cells
CIITA-driven MHC-II positive tumor cells: Preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy
✍ Valeria Frangione; Lorenzo Mortara; Patrizia Castellani; Andrea De Lerma Barbaro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 987 KB

## Abstract In our study, we have investigated whether tumors of distinct histological origin can be rejected if expressing CIITA‐driven MHC class II molecules. Moreover, we assessed whether antitumor lymphocytes generated by this approach could be used as an immunotherapeutic tool for established

Regulation of CTL responses to MHC-restr
Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC–mGM-CSF
✍ Murrium Ahmad; Robert C. Rees; Stephanie E. McArdle; Geng Li; Shahid Mian; Clair 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 376 KB

## Abstract Direct intratumour injection of the disabled infectious single‐cycle–herpes simplex virus–encoding murine granulocyte/macrophage colony‐stimulating factor (DISC‐HSV–mGM‐CSF) into established colon carcinoma CT26 tumours induced complete tumour rejection in up to 70% of treated animals (